ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
In transition: Commercializing fusion power
Commercial fusion power is closer than ever. There are now around 30 U.S. fusion companies, several of which claim to be on track to connect to the grid as early as the 2030s.
Tokamak and laser inertial confinement approaches benefit from decades of research at facilities such as the National Ignition Facility (NIF) at Lawrence Livermore National Laboratory and ITER, with alternative concepts including stellarator, magnetic mirror, and Z-pinch confinement also making notable progress as private and government funding for fusion increases.
Otto K. Harling, Jacquelyn C. Yanch, J. Richard Choi, Guido R. Solares, Ronald D. Rogus, Damien J. Moulin, L. Scott Johnson, Ilhan Olmez, Stefan Wirdzek, John A. Bernard, Robert G. Zamenhof, Charles I. Nwanguma, David E. Wazer, Stephen Saris,Hywel Madoc-Jones,Clement B. Sledge, Sonya Shortkroff
Nuclear Science and Engineering | Volume 110 | Number 4 | April 1992 | Pages 330-348
Technical Paper | doi.org/10.13182/NSE92-A23907
Articles are hosted by Taylor and Francis Online.
Current research in boron neutron capture therapy (BNCT) and radiation synovectomy at the Massachusetts Institute of Technology Research Reactor is reviewed. In the last few years, major emphasis has been placed on the development of BNCT primarily for treatment of brain tumors. This has required a concerted effort in epithermal beam design and construction as well as the development of analytical capabilities for 10B analysis and patient treatment planning. Prompt gamma analysis and high-resolution track-etch autoradiography have been developed to meet the needs, respectively, for accurate bulk analysis and for quantitative imaging of 10B in tissue at subcellular resolutions. Monte Carlo-based treatment planning codes have been developed to ensure optimized and individualized patient treatments. In addition, the development of radiation synovectomy as an alternative therapy to surgical intervention in joints that are affected by rheumatoid arthritis is described.